Brought to you by:
Bryan Kay
Study demonstrates textbook outcomes occur less than a quarter of the time after CLTI revascularization
Textbook outcomes remain “very rare” after revascularization for chronic limb-threatening ischemia (CLTI), with the main driver being an enduring inability to attain complete wound healing and to return patients to their preoperative ambulatory status, according to the lead researcher behind…
BEST-CLI trial spline model analysis breaks new ground in assessing the impact of CKD severity on CLTI outcomes
A new analysis of the BEST-CLI trial has produced the first evidence-based glomerular filtration rate (eGFR) value—30 mL m2—as the cutoff below which patients with chronic limb-threatening ischemia (CLTI) experience significantly worse outcomes after revascularization regardless of the treatment modality…
Deep vein arterialization: Much remains to be learned but use poised to expand in patients with less severe ischemia
These remain early days for transcatheter arterialization of the deep veins (TADV) in the setting of patients with severe chronic limb-threatening ischemia (CLTI), says Daniel Clair, MD, one of the principal investigators in key clinical trials of the procedure, but…
Akura Medical enrols first patient in QUADRA-PE study
Akura Medical has announced today the first patient enrolment in the QUADRA-PE study evaluating the Katana thrombectomy system in patients with acute pulmonary embolism (PE). The initial procedure was successfully performed by Samuel Horr, director of cardiovascular research at TriStar Centennial…
Penumbra launches Element vascular access system for VTE
Penumbra recently announced the launch of its Element vascular access system. This is the first laser-cut hypotube sheath designed for venous thromboembolism (VTE), the company shares in a press release. Penumbra notes that Element is compatible with the Lightning Flash…
US ARC uncovers ‘dramatic’ decrease in use of prophylactic spinal drains at same time as spinal cord ischemia steeply declines
Despite a “dramatic” decrease in the use of prophylactic cerebrospinal fluid drains (CSFDs) for the prevention of spinal cord ischemia (SCI) in patients undergoing fenestrated and branched endovascular aortic repair (F/BEVAR), the rate of SCI has tracked a similarly dramatic…
Tracci assumes presidency of Southern Vascular
Margaret (Megan) Tracci, MD, has become the first-ever woman president of the Southern Association for Vascular Surgery (SAVS). The University of Virginia professor of surgery assumed the role at the close of the 2025 SAVS annual meeting in St. Thomas,…
FDA announces plans to address medical device shortage risks
The Food and Drug Administration (FDA) has issued a statement outlining measures to enhance protections against medical device shortages. According to Michelle Tarver, director of the FDA’s Center for Devices and Radiological Health (CDRH), supply chain disruptions—often caused by natural…
One-year SAVVE trial results are ‘most encouraging data ever produced for a bioprosthetic vein valve’
The one-year data from the SAVVE trial represent the “most encouraging clinical data that have ever been produced for a bioprosthetic deep vein valve” in more than half a century of attempts at developing such a device, according to one…
Study reports lack of evidence to support theory that hospital integration improves value of healthcare
A systematic review of U.S. literature focused on analyzing the effects of mergers and acquisitions on healthcare suggests that there is a lack of evidence to support the theory that integration is an effective strategy for improving the value of…